223 related articles for article (PubMed ID: 21206133)
1. Intestinal absorption of HMG-CoA reductase inhibitor pitavastatin mediated by organic anion transporting polypeptide and P-glycoprotein/multidrug resistance 1.
Shirasaka Y; Suzuki K; Shichiri M; Nakanishi T; Tamai I
Drug Metab Pharmacokinet; 2011; 26(2):171-9. PubMed ID: 21206133
[TBL] [Abstract][Full Text] [Related]
2. Species difference in the effect of grapefruit juice on intestinal absorption of talinolol between human and rat.
Shirasaka Y; Kuraoka E; Spahn-Langguth H; Nakanishi T; Langguth P; Tamai I
J Pharmacol Exp Ther; 2010 Jan; 332(1):181-9. PubMed ID: 19779132
[TBL] [Abstract][Full Text] [Related]
3. Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide.
Shirasaka Y; Suzuki K; Nakanishi T; Tamai I
Pharm Res; 2010 Oct; 27(10):2141-9. PubMed ID: 20686826
[TBL] [Abstract][Full Text] [Related]
4. Concentration-dependent effect of naringin on intestinal absorption of beta(1)-adrenoceptor antagonist talinolol mediated by p-glycoprotein and organic anion transporting polypeptide (Oatp).
Shirasaka Y; Li Y; Shibue Y; Kuraoka E; Spahn-Langguth H; Kato Y; Langguth P; Tamai I
Pharm Res; 2009 Mar; 26(3):560-7. PubMed ID: 19002566
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of grapefruit juice on intestinal absorption of statins due to inhibition of organic anion transporting polypeptide and/or P-glycoprotein.
Shirasaka Y; Suzuki K; Nakanishi T; Tamai I
J Pharm Sci; 2011 Sep; 100(9):3843-53. PubMed ID: 21520088
[TBL] [Abstract][Full Text] [Related]
6. Active intestinal absorption of fluoroquinolone antibacterial agent ciprofloxacin by organic anion transporting polypeptide, Oatp1a5.
Arakawa H; Shirasaka Y; Haga M; Nakanishi T; Tamai I
Biopharm Drug Dispos; 2012 Sep; 33(6):332-41. PubMed ID: 22899169
[TBL] [Abstract][Full Text] [Related]
7. Transporter-mediated intestinal absorption of fexofenadine in rats.
Kikuchi A; Nozawa T; Wakasawa T; Maeda T; Tamai I
Drug Metab Pharmacokinet; 2006 Aug; 21(4):308-14. PubMed ID: 16946558
[TBL] [Abstract][Full Text] [Related]
8. Transporter-mediated influx and efflux mechanisms of pitavastatin, a new inhibitor of HMG-CoA reductase.
Fujino H; Saito T; Ogawa S; Kojima J
J Pharm Pharmacol; 2005 Oct; 57(10):1305-11. PubMed ID: 16259759
[TBL] [Abstract][Full Text] [Related]
9. Intestinal absorption mechanism of mirabegron, a potent and selective β₃-adrenoceptor agonist: involvement of human efflux and/or influx transport systems.
Takusagawa S; Ushigome F; Nemoto H; Takahashi Y; Li Q; Kerbusch V; Miyashita A; Iwatsubo T; Usui T
Mol Pharm; 2013 May; 10(5):1783-94. PubMed ID: 23560393
[TBL] [Abstract][Full Text] [Related]
10. Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells.
Su Y; Zhang X; Sinko PJ
Mol Pharm; 2004 Jan; 1(1):49-56. PubMed ID: 15832500
[TBL] [Abstract][Full Text] [Related]
11. Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.
Prueksaritanont T; Chu X; Evers R; Klopfer SO; Caro L; Kothare PA; Dempsey C; Rasmussen S; Houle R; Chan G; Cai X; Valesky R; Fraser IP; Stoch SA
Br J Clin Pharmacol; 2014 Sep; 78(3):587-98. PubMed ID: 24617605
[TBL] [Abstract][Full Text] [Related]
12. Delineating the contribution of secretory transporters in the efflux of etoposide using Madin-Darby canine kidney (MDCK) cells overexpressing P-glycoprotein (Pgp), multidrug resistance-associated protein (MRP1), and canalicular multispecific organic anion transporter (cMOAT).
Guo A; Marinaro W; Hu P; Sinko PJ
Drug Metab Dispos; 2002 Apr; 30(4):457-63. PubMed ID: 11901101
[TBL] [Abstract][Full Text] [Related]
13. Characterization of gastrointestinal absorption of digoxin involving influx and efflux transporter in rats: application of mdr1a knockout (-/-) rats into absorption study of multiple transporter substrate.
Suzuki M; Komura H; Yoshikawa T; Enya S; Nagao A; Takubo H; Kogayu M
Xenobiotica; 2014 Nov; 44(11):1039-45. PubMed ID: 24839994
[TBL] [Abstract][Full Text] [Related]
14. Metabolic stability and uptake by human hepatocytes of pitavastatin, a new inhibitor of HMG-CoA reductase.
Fujino H; Nakai D; Nakagomi R; Saito M; Tokui T; Kojima J
Arzneimittelforschung; 2004; 54(7):382-8. PubMed ID: 15344842
[TBL] [Abstract][Full Text] [Related]
15. Drug-drug interaction between pitavastatin and various drugs via OATP1B1.
Hirano M; Maeda K; Shitara Y; Sugiyama Y
Drug Metab Dispos; 2006 Jul; 34(7):1229-36. PubMed ID: 16595711
[TBL] [Abstract][Full Text] [Related]
16. Intestinal absorption mechanism of tebipenem pivoxil, a novel oral carbapenem: involvement of human OATP family in apical membrane transport.
Kato K; Shirasaka Y; Kuraoka E; Kikuchi A; Iguchi M; Suzuki H; Shibasaki S; Kurosawa T; Tamai I
Mol Pharm; 2010 Oct; 7(5):1747-56. PubMed ID: 20735088
[TBL] [Abstract][Full Text] [Related]
17. Grapefruit juice and its constituents augment colchicine intestinal absorption: potential hazardous interaction and the role of p-glycoprotein.
Dahan A; Amidon GL
Pharm Res; 2009 Apr; 26(4):883-92. PubMed ID: 19048359
[TBL] [Abstract][Full Text] [Related]
18. Involvement of BCRP (ABCG2) in the biliary excretion of pitavastatin.
Hirano M; Maeda K; Matsushima S; Nozaki Y; Kusuhara H; Sugiyama Y
Mol Pharmacol; 2005 Sep; 68(3):800-7. PubMed ID: 15955871
[TBL] [Abstract][Full Text] [Related]
19. Effects of itraconazole, dexamethasone and naringin on the pharmacokinetics of nadolol in rats.
Miyazaki N; Misaka S; Ogata H; Fukushima T; Kimura J
Drug Metab Pharmacokinet; 2013; 28(4):356-61. PubMed ID: 23419354
[TBL] [Abstract][Full Text] [Related]
20. Interaction of macrolide antibiotics with intestinally expressed human and rat organic anion-transporting polypeptides.
Lan T; Rao A; Haywood J; Davis CB; Han C; Garver E; Dawson PA
Drug Metab Dispos; 2009 Dec; 37(12):2375-82. PubMed ID: 19741038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
